P01-45 Twenty-four months efficacy and safety of LB03002, a new sustained release formulation of rhGH, in children with GHD: Extension of a phase III randomized multicentre study

Saved in:
Bibliographic Details
Published in:Growth hormone & IGF research 2012-10, Vol.22, p.S48-S48
Main Authors: Saenger, P, Khadilkar, V, Radjuk, K.A, Bolshova, E, Khadgawat, R, El Kholy, M, Desai, M, Peterkova, V, Mericq, V, Ji, H.-J, Bae, Y.J, Lopez, P, Martin, D
Format: Article
Language:English
Subjects:
Advanced Basic Science
Endocrinology & Metabolism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1096-6374
1532-2238
DOI:10.1016/S1096-6374(12)60124-5